Teratocarcinoma cell MHC antigen expression is regulated in vitro by a soluble noninterferon factor
- 1 May 1986
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 99 (2) , 453-460
- https://doi.org/10.1016/0008-8749(86)90253-4
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfectionNature, 1985
- T-cell subsets in tumour rejection responsesImmunology Today, 1985
- Regulation of major histocompatibility gene expression in teratocarcinoma 402AX cellsCell Differentiation, 1984
- Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformationNature, 1984
- Serologic cross-reactivity between Class I MHC molecules and an H-2-linked differentiation antigen as detected by monoclonal antibodies.The Journal of Experimental Medicine, 1984
- A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation-induced leukemia virus. Enhancement of effective tumor surveillance by killer lymphocytes.The Journal of Experimental Medicine, 1979
- Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumorThe Journal of Experimental Medicine, 1975
- H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus.The Journal of Experimental Medicine, 1975
- Cell‐mediated cytotoxicity to trinitrophenyl‐modified syngeneic lymphocytesEuropean Journal of Immunology, 1974
- ABSENCE OF SEROLOGICALLY DETECTABLE H-2 ON PRIMITIVE TERATOCARCINOMA CELLS IN CULTURETransplantation, 1974